Frontier Capital Management CO LLC Pacific Biosciences Of California, Inc. Transaction History

Frontier Capital Management CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.41 $5.79 Million - $7.24 Million	-977,464 Closed	0 $0
Q1 2019 May 07, 2019	SELL	$6.8 - $7.4 $461,590 - $502,319	-67,881 Reduced 6.49%	977,464 $7.07 Million
Q4 2018 Jan 25, 2019	SELL	$3.99 - $7.82 $1.33 Million - $2.6 Million	-333,113 Reduced 24.17%	1,045,345 $7.74 Million
Q3 2018 Oct 30, 2018	SELL	$3.52 - $5.55 $179,685 - $283,310	-51,047 Reduced 3.57%	1,378,458 $7.46 Million
Q2 2018 Aug 03, 2018	SELL	$2.11 - $3.92 $48,947 - $90,936	-23,198 Reduced 1.6%	1,429,505 $5.08 Million
Q1 2018 Apr 30, 2018	SELL	$2.05 - $3.23 $14,434 - $22,742	-7,041 Reduced 0.48%	1,452,703 $2.98 Million
Q4 2017 Jan 18, 2018	SELL	$2.59 - $5.44 $73,263 - $153,881	-28,287 Reduced 1.9%	1,459,744 $3.85 Million
Q3 2017 Oct 31, 2017	BUY	$3.2 - $5.57 $4.76 Million - $8.29 Million	1,488,031	1,488,031 $7.81 Million

253

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $405M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.